George Golumbeski

George Golumbeski

Net worth: 303 648 $ as of 2026-10-30

68 year
Health Technology
Commercial Services
Finance

Profile

George S.
Golumbeski
is currently Chairman at Carrick Therapeutics UK Ltd., Verseau Therapeutics, Inc., Actio Biosciences, Inc., National Audubon Society, Inc., Carrick Therapeutics, Inc., and Acumen Pharmaceuticals, Inc. He serves as Independent Chairman at Shattuck Labs, Inc., Non-Executive Director at Faron Pharmaceuticals Oy, and Director at Corbus Pharmaceuticals, Inc., BlackThorn Therapeutics, Inc., Tusk Therapeutics Ltd., and Peptone Ltd. He is a Trustee at Keck Graduate Institute of Applied Life Sciences, Partner at Droia Ventures, and Venture Advisor at Vertex Ventures HC.
Former roles include Chief Executive Officer at Nabriva Therapeutics GmbH, Chairman at Aura Biosciences, Inc., BioSight Ltd., and Ananke Therapeutics, Inc., Deputy Chairman-Supervisory Board at MorphoSys AG, Independent Director at SAGE Therapeutics, Inc., Independent Director at Acceleron Pharma, Inc., Independent Director at Enanta Pharmaceuticals, Inc., President & Director at GRAIL, Inc., Director at Corbus Pharmaceuticals Holdings, Inc., Director-Business Development at Pierce Biotechnology, Inc., Vice President & Director-Corporate Development at Schwarz Pharma, Inc., Senior Director-Licensing at EMD Pharmaceuticals, Inc., Vice President-Business Development at Elan Pharmaceuticals LLC, VP-Business Development, Licensing & Strategy at Novartis Oncology, Inc., Executive Vice President-Innovation at Celgene Corp., Manager-Technology Acquisition at Promega Corp., and Independent Director at Mural Oncology Plc.
Education includes a doctorate from the University of Wisconsin conferred in 1985 and an undergraduate degree from the University of Virginia conferred in 1979.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-28 54,613 ( 0.05% ) 303 648 $ 2026-10-30
2026-06-02 0 ( -.--% ) - $ 2026-10-30

George Golumbeski active positions

CompaniesPositionStart
SHATTUCK LABS, INC. Chairman 2021-10-21
ACUMEN PHARMACEUTICALS, INC. Chairman 2025-11-05
FARON PHARMACEUTICALS OY Director/Board Member 2026-05-04
Chairman 2024-09-27
Chairman 2018-10-10
Chairman 2019-10-19
Chairman -
Chairman -
Director/Board Member 2012-12-31
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of George Golumbeski

CompaniesPositionEnd
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of George Golumbeski's experience

Education of George Golumbeski

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

39

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies39

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. George Golumbeski